Rick Stevens

Accelerated Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in development of pre-existing pharmaceutical products for the treatment of various cancer indications. It offers a platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications under the Picoplatin brand. The company was founded by Michael Fonstein, Ekaterina E. Nikolaevskaya and Dmitry Prudnikov in May 2014 and is headquartered in Westport, CT.

The National Science Foundation supports fundamental science and engineering researches. It offers services to people in all scientific and engineering disciplines. The firm focuses on the promotion and progress of science to advance the national health, prosperity and welfare. The company was founded in 1950 and is headquartered in Arlington, VA.